{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-N-2590", "FDA", "Microbiology Devices; Reclassification of Mycobacterium tuberculosis Cell-Mediated Immunity Tests and Immune Response Enzyme-Linked Immunospot Tests", "Nonrulemaking", "2026-05-06T14:04:04Z", "0b000064b9210e9a"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-N-2590"], "units": {}, "query_ms": 0.49548596143722534, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}